PNOC019: Neoadjuvant Checkpoint Inhibition in Recurrent or Progressive HGG

Who Can Participate in the Study?

Age Group
Both

Study Details

Full Title
A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Principal Investigator
Headshot of Daniel Bryce Landi
Associate Professor of Pediatrics
Protocol Number
IRB: PRO00109073
NCT: NCT04323046
Phase
Phase Pilot
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL
Participate